Empower Advisory Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $244K | Sell |
549
-86
| -14% | -$38.3K | ﹤0.01% | 446 |
|
|
2025
Q1 | $308K | Sell |
635
-27
| -4% | -$13.1K | ﹤0.01% | 395 |
|
|
2024
Q4 | $267K | Buy |
662
+47
| +8% | +$18.9K | ﹤0.01% | 432 |
|
|
2024
Q3 | $286K | Sell |
615
-11
| -2% | -$5.12K | ﹤0.01% | 410 |
|
|
2024
Q2 | $293K | Buy |
626
+29
| +5% | +$13.6K | ﹤0.01% | 398 |
|
|
2024
Q1 | $250K | Sell |
597
-28
| -4% | -$11.7K | ﹤0.01% | 448 |
|
|
2023
Q4 | $254K | Buy |
625
+2
| +0.3% | +$814 | ﹤0.01% | 424 |
|
|
2023
Q3 | $217K | Sell |
623
-64
| -9% | -$22.3K | ﹤0.01% | 433 |
|
|
2023
Q2 | $242K | Sell |
687
-47
| -6% | -$16.5K | ﹤0.01% | 436 |
|
|
2023
Q1 | $232K | Buy |
+734
| New | +$232K | ﹤0.01% | 444 |
|